Latest
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
We know research matters to you. This month, explore our top articles of the year – featuring the MS-gut connection and other fresh off the press findings in MS research.
- Jul 2024
iConquerMS will launch the largest study ever on a new treatment for MS fatigue.
- Jul 2024
Research studies include one for Kesimpta users, exploration into childhood experiences, and a study on exercise and wellness for wheelchair users.
- Jul 2024
Your donation to ACP enables iConquerMS to bring together all people affected by MS to understand the disease and search for solutions.
- Jul 2024
Not enough time to read an entire newsletter? Our July newsletter snapshot contains the highlights in a quick, easy to read format.
- Jul 2024
Heat intolerance is a common, debilitating MS symptom. Discover ways to stay cool and find relief!
- Jul 2024
iConquerMS is revolutionizing MS research through patient-powered innovation!